Abstract:Purpose: This study aimed to investigate the diagnostic and prognostic values of neuropilin-1 (NRP-1) in triple-negative breast cancer (TNBC) and analyze its immune function in the tumor microenvironment. Methods: Based on The Cancer Genome Atlas (TCGA), Gene Expression Omnibus, Genotype Tissue Expression, Immune Cell Abundance Identifier (ImmuCellAI), Reactome, and Genomics of Drug Sensitivity in Cancer databases, the cancer tissues from 50 patients with TNBC and corresponding adjacent noncancerous tissues from 10 patients (tissue microarrays were purchased from Shanghai Xinchao Biotechnology Co., Ltd.) were collected for validation. Bioinformatics combined with immunohistochemistry was used to analyze the relationship among NRP-1 expression, prognosis, tumor immune cell infiltration, immune genes, and drug resistance so as to investigate the role of NRP-1 in the development of TNBC. Results: A significant difference in NRP-1 gene expression was found between the cancerous and noncancerous tissues (p-value < 0.05); NRP-1 expression was high in carcinoma. No significant correlation was found between NRP-1 protein expression levels and each stage in the TCGA database. Prognostic expression survival analysis showed that the survival probability of patients with high NRP-1 expression was significantly lower than that of patients with low NRP-1 expression (p-value < 0.05), suggesting that the gene might be a pro-oncogene. The data from 50 clinical samples also confirmed that the NRP-1 expression was significantly higher in triple-negative breast cancer (TNBC) tissues than in adjacent noncancerous tissues. The NRP-1 expression significantly correlated with the tumor diameter and pathological grade (p-value < 0.05), but not with age, stage, and ki67 (p-value > 0.05). The Kaplan-Meier survival curves suggested that the median overall survival was significantly shorter in patients with high NRP-1 expression than in those with low NRP-1 expression (13.6 months vs 15.2 months, p-value < 0.05). The 300 genes most significantly positively associated with this gene were selected for Gene Ontology (including Biological Process, Molecular Function, and Cellular Component groups) and Kyoto Encyclopedia of Genes and Genomics enrichment analysis. The findings showed that NRP-1 was involved in immune regulation in TNBC. In addition, the NRP-1 expression in TNBC positively correlated with a variety of immune cells and checkpoints. Conclusion: NRP-1 can be used as a potential biomarker and therapeutic target in TNBC.

Clinical Significance of Nob1 Expression in Breast Infiltrating Ductal Carcinoma

Expression of the NOB1 Gene and Its Clinical Significance in Papillary Thyroid Carcinoma

Prognostic Value of NOB1 Expression Levels in Various Cancers: a Systematic Review and Meta-Analysis.

Nin one binding protein expression as a prognostic marker in prostate carcinoma

Positive Nin One Binding Protein Expression Predicts Poor Outcome in Prostate Cancer.

EXPRESSION MECHANISM AND CLINICAL SIGNIFICANCE OF NOB1 IN GASTRIC CANCER TISSUE AND ADJACENT NORMAL TISSUE.

Pan-cancer exploration of PNO1: A prospective prognostic biomarker with ties to immune infiltration

The oncogenic potentials and diagnostic significance of long non-coding RNA LINC00310 in breast cancer.

NOB1 Gene As a Potential Biomarker in Clinical Outcomes and Prognosis of Patients with Gastric Cancer.

Expression of NOB1 Gene and Its Clinical Significance in Ovarian Cancer

Lnc00113 promotes triple‐negative breast cancer progression via the NOB‐1/MAPK signaling axis

Downregulation of NOB1 suppresses the proliferation and tumor growth of non-small cell lung cancer in vitro and in vivo.

Expression And Clinical Significance Of The Nin One Binding Protein And P38 Mapk In Prostate Carcinoma

Sirna Mediated Silencing of NIN1/RPN12 Binding Protein 1 Homolog Inhibits Proliferation and Growth of Breast Cancer Cells.

Clinicopathological Significance and Underlying Molecular Mechanism of Downregulation of Basonuclin 1 Expression in Ovarian Carcinoma.

Bioinformatics analysis and clinical significance of NRP-1 in triple-negative breast cancer

Clinical Implications of High NQO1 Expression in Breast Cancers

Adenovirus-mediated siRNA targeting NOB1 inhibits tumor growth and enhances radiosensitivity of human papillary thyroid carcinoma in vitro and in vivo.

Silencing NOB1 Can Affect Cell Proliferation and Apoptosis Via the C-Jun N-Terminal Kinase Pathway in Colorectal Cancer

Expression of Nuclear Factor-κB and Its Clinical Significance in Nonsmall-Cell Lung Cancer

Inhibition of NOB1 by Microrna-330-5p Overexpression Represses Cell Growth of Non-Small Cell Lung Cancer.